Arcadia Biosciences, Inc. (RKDA)
NASDAQ: RKDA · Real-Time Price · USD
6.35
+0.13 (2.09%)
Dec 20, 2024, 4:00 PM EST - Market closed
Company Description
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States.
The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients.
Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.
The company was incorporated in 2002 and is headquartered in Dallas, Texas.
Arcadia Biosciences, Inc.
| Country | United States |
| Founded | 2002 |
| IPO Date | May 15, 2015 |
| Industry | Packaged Foods |
| Sector | Consumer Staples |
| Employees | 21 |
| CEO | Thomas Schaefer |
Contact Details
Address: 5950 Sherry Lane, Suite 215 Dallas, Texas 75225 United States | |
| Phone | 214 974 8921 |
| Website | arcadiabio.com |
Stock Details
| Ticker Symbol | RKDA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001469443 |
| CUSIP Number | 039014204 |
| ISIN Number | US0390143032 |
| Employer ID | 81-0571538 |
| SIC Code | 0100 |
Key Executives
| Name | Position |
|---|---|
| Thomas J. Schaefer C.F.A. | Chief Executive Officer, President and Director |
| Mark Kawakami | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 11, 2024 | 425 | Filing |
| Dec 11, 2024 | 8-K | Current Report |
| Dec 6, 2024 | 425 | Filing |
| Dec 6, 2024 | 8-K | Current Report |
| Nov 22, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Nov 12, 2024 | 10-Q | Quarterly Report |
| Nov 12, 2024 | 8-K | Current Report |
| Aug 23, 2024 | 8-K/A | [Amend] Current report |
| Aug 13, 2024 | 10-Q | Quarterly Report |
| Aug 13, 2024 | 8-K | Current Report |